Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Total Non-Current Liabilities: 2011-2021

Historic Total Non-Current Liabilities for SELLAS Life Sciences Group (SLS) over the last 5 years, with Dec 2021 value amounting to $5.6 million.

  • SELLAS Life Sciences Group's Total Non-Current Liabilities rose 109.76% to $13.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $13.2 million, marking a year-over-year increase of 109.76%. This contributed to the annual value of $5.6 million for FY2021, which is 58.14% down from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Total Non-Current Liabilities of $5.6 million as of FY2021, which was down 58.14% from $13.5 million recorded in FY2020.
  • In the past 5 years, SELLAS Life Sciences Group's Total Non-Current Liabilities registered a high of $13.5 million during FY2020, and its lowest value of $5.6 million during FY2019.
  • For the 3-year period, SELLAS Life Sciences Group's Total Non-Current Liabilities averaged around $8.2 million, with its median value being $5.6 million (2021).
  • As far as peak fluctuations go, SELLAS Life Sciences Group's Total Non-Current Liabilities soared by 140.10% in 2020, and later tumbled by 58.14% in 2021.
  • SELLAS Life Sciences Group's Total Non-Current Liabilities (Yearly) stood at $5.6 million in 2019, then spiked by 140.10% to $13.5 million in 2020, then tumbled by 58.14% to $5.6 million in 2021.